img

#1

US IPO Issuance in 2022 - 2024 YTD3

img

#1

SPAC issuance in 2022 - 2024 YTD2

img

$23B+

in Gross Proceeds Raised3

img

300+

Transactions Completed3

Recent Transactions
November 25, 2024
img
img
Armlogi Holding Corp
(Nasdaq: BTOC)

$50,000,000

Private Placement
Exclusive Placement Agent

November 20, 2024
img
img
Nova Vision Acquisition Corp Merger with Real Messenger
(Nasdaq: NOVV)

$64,000,000

Business Combination
Capital Markets Advisor

November 15, 2024
img
img
374Water Inc.
(Nasdaq: SCWO)

$12,229,370

Registered Direct Offering
Exclusive Placement Agent

November 14, 2024
img
img
Pineapple Financial, Inc.
(Nasdaq: PAPL)

$1,000,000

Registered Direct Offering
Exclusive Placement Agent

November 12, 2024
img
img
Nature’s Miracle Holding Inc.
(Nasdaq: NMHI)

$3,000,000

Underwritten Public Offering
Sole Bookrunner

November 8, 2024
img
img
Aduro Clean Technologies Inc.
(Nasdaq: ADUR)

$4,000,000

Uplisting
Co-Underwriter

October 24, 2024
img
img
Li Bang International Corporation Inc.
(Nasdaq: LBGJ)

$6,080,000

Initial Public Offering
Joint Bookrunner

October 23, 2024
img
img
HUHUTECH International Group Inc.
(Nasdaq: HUHU)

$4,200,000

Initial Public Offering
Joint Bookrunner

October 15, 2024
img
img
MicroVision, Inc.
(Nasdaq: MVIS)

$75,000,000

Private Placement
Placement Agent

October 4, 2024
img
img
Humacyte, Inc.
(Nasdaq: HUMA)

$30,000,000

Registered Direct Offering
Exclusive Placement Agent

September 26, 2024
img
img
Acri Capital Acquisition Corporation Merger with Foxx Development Holdings Inc.
(Nasdaq: FOXX)

~$50,000,000

Business Combination
Capital Markets Advisor

September 23, 2024
img
img
Zhibao Technology Inc.
(Nasdaq: ZBAO)

$7,200,000

Private Placement
Exclusive Placement Agent

1 2 3 4 5 34
Insights
  • April 9, 2025

    D. Boral Capital Acted as Sole Bookrunner to FatPipe, Inc. (Nasdaq: FATN) in connection with its $4.0 Million Initial Public Offering

  • March 27, 2025

    D. Boral Capital Acted as Sole Bookrunner to Epsium Enterprise Limited (Nasdaq: EPSM) in connection with its $5.0 Million Initial Public Offering

  • March 26, 2025

    D. Boral Capital Acted as Exclusive Placement Agent to Inspire Veterinary Partners, Inc. (Nasdaq: IVP) in connection with its up to $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

  • March 4, 2025

    D. Boral Capital Served as Exclusive Placement Agent to Plus Therapeutics, Inc. (Nasdaq: PSTV) in connection with its up to $15.0 Million Private Placement

img

Together, let's build meaningful value.